Torvast Safety Questions, Torvast Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Torvast side effects. Check out Health Surveys and Health Polls. If you have questions about Torvast, you can post them to our Doctors or Ask Patient Community about Torvast.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Torvast
Torvast Safety Reports
Total Torvast reports: 5.Torvast FDA safety alerts: 2003 2005 .
Reported hospitalizations: 1.
Take Torvast Side Effects Survey or Share Your Torvast Story.
Reported Torvast Side Effects: white blood cell disorder, vomiting, rash, oliguria, nausea, eosinophil percentage increased, diarrhoea, thrombocytopenia, lymphopenia, white blood cell count increased, gamma-glutamyltransferase increased.
More About Torvast.
Torvast Side Effects Report #5069796-2
Physician from ITALY reported TORVAST problem on July 21, 2006. Male patient, 73 years of age, was diagnosed with infarction and was treated with TORVAST. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, hepatitis cholestatic. TORVAST dosage: 20 MG (20 MG, 1IN 1 D), ORAL. During the same period patient was treated with RAMIPRIL, METOPROLOL TARTRATE, ACETYLSALICYLIC ACID SRT, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Torvast Side Effects Report #5112573-4
TORVAST problem was reported by a Physician from ITALY on Sept 08, 2006. Female patient was treated with TORVAST. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased. TORVAST dosage: 20 MG. During the same period patient was treated with ANASTROZOLE. Patient recovered.
Torvast Side Effects Report #5141803-8
Physician from ITALY reported TORVAST problem on Oct 20, 2006. Male patient, 72 years of age, was diagnosed with coronary angioplasty and was treated with TORVAST. After drug was administered, patient experienced the following problems/side effects: diarrhoea, eosinophil percentage increased, nausea, oliguria, rash, vomiting, white blood cell disorder. TORVAST dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PLAVIX, ASCRIPTIN, RAMIPRIL. Patient recovered.
Torvast Side Effects Report #5196354-1
TORVAST problem was reported by a Physician from ITALY on Dec 14, 2006. Male patient, 72 years of age, was diagnosed with coronary angioplasty and was treated with TORVAST. After drug was administered, patient experienced the following problems/side effects: diarrhoea, eosinophil percentage increased, nausea, oliguria, rash, vomiting, white blood cell count increased, white blood cell disorder. TORVAST dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PLAVIX, ASCRIPTIN, RAMIPRIL. Patient recovered.
Torvast Side Effects Report #5406654-5
Consumer or non-health professional from ITALY reported TORVAST problem on July 25, 2007. Male patient, 84 years of age, was diagnosed with hyperlipidaemia and was treated with TORVAST. After drug was administered, patient experienced the following problems/side effects: lymphopenia, thrombocytopenia. TORVAST dosage: unknown. During the same period patient was treated with ZESTRIL. Patient recovered.